Case Study: Global 500 Pharmaceuticals Company reduces risk posture by 25% with Kenna Security

Global 500 Pharmaceuticals Company - Customer Case Study

Global 500 Pharmaceuticals Company turned to **Kenna Security** after struggling with too many vulnerabilities, limited context for decision-making, and no effective way to prioritize or quantify risk. The company had previously relied on other vulnerability management tools and Archer VRM/VA, but still faced inefficiencies in remediation and limited IT commitment due to the volume of findings.

By implementing the **Kenna Security Platform**, the company gained a threat-driven, data science-based approach with real-time exploit intelligence, broad integrations, and integrated remediation/ticketing. **Kenna Security** helped them focus on the highest-risk vulnerabilities, improve remediation efficiency, and turn security data into actionable intelligence, resulting in a **25% reduction in risk posture score**.